期刊文献+

高钙危象临床报告2例

下载PDF
导出
摘要 1临床资料病例1,患者,女,38岁,因“全身乏力伴关节酸痛1周,加重伴腹胀、发现血钙升高1 d”入院。1年前因“双肾结石”行“体外冲击波碎石”,2周前行“超声波碎石”。查体:生命体征平稳,甲状腺左侧扪及3 cm×3 cm左右包块,随吞咽上下移动,心肺腹及神经系统无阳性发现。实验室及影像学检查:血钙5.07 mmol/L(正常参考值:2.09~2.54 mmol/L),磷1.05 mmol/L(正常参考值:0.8~1.5 mmol/L),钾3.66 mmol/L(正常参考值:3.5~5.3 mmol/L),钠137 mmol/L(正常参考值:135~145 mmol/L),镁0.74 mmol/L(正常参考值:0.65~1.10 mmol/L),血尿酸451μmol/L(正常参考值:90~420μmol/L),血尿素8.86 mmol/L(正常参考值:2.1~7.2 mmol/L),血肌酐151μmol/L(正常参考值:45~84μmol/L),甲状旁腺激素PTH 1618.80 pg/ml(正常参考值:12~88 pg/ml),碱性磷酸酶AKP 443 U(正常参考值:30~120 U),肿瘤标志物、体液免疫、ANCA全套、甲状腺功能、肝功能、血糖、常规等检查正常。
出处 《四川医学》 CAS 2021年第10期1069-1071,共3页 Sichuan Medical Journal
  • 相关文献

参考文献4

二级参考文献33

  • 1邢小平,孟迅吾,詹志伟,刘书勤,朱预,管珩.高钙危象的初步诊治经验(附23例临床分析)[J].中国医学科学院学报,1994,16(2):116-121. 被引量:14
  • 2Major P, Lortholary A, Hon J, et al. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oneol, 2001, 19:558-567.
  • 3Body JJ. Hypercalcemia of malignancy. Semin Nephrol, 2004, 24 : 48-54.
  • 4Markowitz GS, Fine PL, Stack JI, et al. Toxic acute tubular necrosis following treatment with zoledronate ( Zometa ). Kidney Int, 2003, 64:281-289.
  • 5Rosen LS, Gordon D, Tchekmedyian S, et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase Ⅲ, doubleblind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol, 2003, 21: 3150- 3157.
  • 6Rosen LS, Gordon D, Kaminski M, et al. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, doubleblind, multicenter, comparative trial. Cancer, 2003, 98: 1735- 1744.
  • 7Maxwell C, Swift R, Goode M, et al. Advances in supportive care of patients with cancer and bone metastases: nursing implications of zoledronic acid. Clin J Oncol Nurs, 2003,7:403-408.
  • 8Pecherstorfer M, Jilch R, Sauty A, et al. Effect of first treatment with aminobisphosphonates pamidronate and ibandronate on circulating lymphocyte subpopulations. J Bone Miner Res, 2000, 15 : 147-154.
  • 9Munns CF, Rauch F, Mier RJ, et al. Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta. Bone, 2004, 35:231-234.
  • 10Fraunfelder FW, Fraunfelder FT, Jensvold B. Scleritis and other ocular side effects associated with pamidronate disodium. Am J Ophthalmol, 2003,135:219-222.

共引文献168

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部